The executive interview as a screening test for executive dysfunction in patients with mild dementia

Area of Science:

• Neurology
• Cognitive Science
• Geriatrics

Background:

• Executive dysfunction is a key feature of mild dementia.
• Screening tools are needed to identify these deficits early.
• The Executive Interview (EXIT25) is a novel screening instrument.

Purpose of the Study:

• To validate the Executive Interview (EXIT25) for screening executive cognitive dysfunction in mild dementia.
• To assess the EXIT25's ability to differentiate patients from healthy controls.
• To determine if EXIT25 scores correlate with other measures of cognitive and functional impairment.

Main Methods:

• A validation study comparing 33 mild dementia patients (MMSE score >=20) with 30 healthy controls.
• Administration of the 25-item EXIT25 to all participants.
• Correlation analysis with traditional neuropsychological tests (e.g., Stroop Test, verbal fluency) and functional scales (e.g., Frontal Behavioral Inventory).

Main Results:

• Patients with mild dementia scored significantly higher on the EXIT25 than healthy controls.
• The Mini-Mental State Examination (MMSE) scores did not fully explain the differences between groups.
• EXIT25 scores showed significant correlations with specific executive function tests and behavioral assessments.

Conclusions:

• The EXIT25 accurately identifies executive cognitive deficits in mild dementia, independent of general cognitive decline.
• The EXIT25 serves as a valuable supplementary tool to the MMSE for clinical assessment of mild dementia.
• This validated screening instrument can aid in the early detection and management of executive dysfunction.